目的:探讨重复经颅磁刺激联合生物反馈用于帕金森病非运动症状的临床疗效及对血清IL-6,CRP及TNF-α水平的影响.方法:收集我院]诊的84例帕金森病患者,随机分为实验组和对照组,每组42例.对照组患者给予肌电、脑电生物反馈治疗,实验组患者在对照组基础上给予重复经颅磁刺激治疗.观察并比较两组患者治疗前后血清C反应蛋白(CRP)、白介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)水平以及非运动症状筛查问卷(NMSQuest)、帕金森病睡眠量表(PDSS)、汉密尔顿抑郁量表(HAMD)评分的变化情况.结果:与治疗前相比,治疗后患者CRP,IL-6及TNF-o水平以及NMSQuest、HAMD评分均下降,而PDSS评分均升高,差异具有统计学意义(P＜0.05);与对照组相比,实验组患者血清CRP,1L-6及TNF-α水平以及NMSQuest、HAMD评分较低,而PDSS评分较高,差异具有统计学意义(P＜0.05).结论:重复经颅磁刺激联合生物反馈能够降低帕金森病患者血清IL-6、CRP、TNF-α水平且对于非运动症状的临床疗效较好.%Objective:To investigate the Repetitive transcranial magnetic stimulation combined with biofeedback non motor symptoms on clinical effects and serum levels of IL-6,CRP and TNF-α of Parkinson's disease.Methods:84 cases of Parkinson's disease in our hospital were randomly divided into experimental group and control group,with 42 cases in each group.The control group were treated with EMG and EEG biofeedback,while the experimental group were treated with repetitive transcranial magnetic stimulation on the basis of the control group.Then the serum levels of C reactive protein (CRP) and interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α),the non motor symptoms questionnaire (NMSQuest),Parkinson's disease Sleep Scale (PDSS) and Hamilton Depression Scale (HAMD) score in the two groups were observed and compared before and after the treatment.Results:Compared with before treatment,the serum levels of CRP,IL-6 and TNF-α,the NMSQuest and HAMD in the two groups decreased after the treatment,while the PDSS score increased,and the differences were statistically significant (P＜0.05);Compared with the control group,the serum levels of CRP,IL-6 and TNF-α,NMSQuest and HAMD in the experimental group were lower,while the PDSS score was higher,and the differences were statistically significant (P＜0.05).Conclusion:Repetitive transcranial magnetic stimulation combined with biofeedback can reduce the serum levels of IL-6,CRP and TNF-α in patients with Parkinson's disease,which has better clinical effect on the non motor symptoms.
展开▼
